Athula Herath

1.6k total citations
19 papers, 839 citations indexed

About

Athula Herath is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Athula Herath has authored 19 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Athula Herath's work include Asthma and respiratory diseases (5 papers), Advanced Proteomics Techniques and Applications (4 papers) and Respiratory and Cough-Related Research (3 papers). Athula Herath is often cited by papers focused on Asthma and respiratory diseases (5 papers), Advanced Proteomics Techniques and Applications (4 papers) and Respiratory and Cough-Related Research (3 papers). Athula Herath collaborates with scholars based in United Kingdom, United States and Canada. Athula Herath's co-authors include R. Reid Townsend, Matthew A. Sleeman, Michael J. O’Hare, Martin Pagé, David E. Amacher, Robert C. Stein, Raj Parekh, Michael D. Waterfield, Rick R. Adler and Marketa Zvelebil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Athula Herath

19 papers receiving 810 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Athula Herath United Kingdom 12 362 200 155 149 125 19 839
Michihiko Waki Japan 17 428 1.2× 50 0.3× 196 1.3× 52 0.3× 70 0.6× 37 766
Laura Spruill United States 17 306 0.8× 99 0.5× 69 0.4× 28 0.2× 16 0.1× 47 680
Christian Woenckhaus Germany 18 433 1.2× 92 0.5× 21 0.1× 66 0.4× 18 0.1× 34 769
A Desplaces France 13 308 0.9× 78 0.4× 25 0.2× 36 0.2× 16 0.1× 40 754
Siu W. Lam Netherlands 12 251 0.7× 102 0.5× 57 0.4× 20 0.1× 20 0.2× 19 753
Jane Hamlett United Kingdom 14 274 0.8× 37 0.2× 68 0.4× 39 0.3× 16 0.1× 27 614
Olivier Guipaud France 18 438 1.2× 224 1.1× 31 0.2× 59 0.4× 12 0.1× 41 933
Yahya Elshimali United States 20 703 1.9× 348 1.7× 26 0.2× 76 0.5× 11 0.1× 36 1.4k
Pyong‐Gon Moon South Korea 13 515 1.4× 53 0.3× 60 0.4× 41 0.3× 5 0.0× 23 691
Isett Laux United States 11 331 0.9× 137 0.7× 22 0.1× 21 0.1× 12 0.1× 14 715

Countries citing papers authored by Athula Herath

Since Specialization
Citations

This map shows the geographic impact of Athula Herath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Athula Herath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Athula Herath more than expected).

Fields of papers citing papers by Athula Herath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Athula Herath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Athula Herath. The network helps show where Athula Herath may publish in the future.

Co-authorship network of co-authors of Athula Herath

This figure shows the co-authorship network connecting the top 25 collaborators of Athula Herath. A scholar is included among the top collaborators of Athula Herath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Athula Herath. Athula Herath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
May, Richard, Michael A. Ghebre, Laura Rapley, et al.. (2021). Sputum biomarkers during acute severe asthma attacks in children—a case‐control study. Acta Paediatrica. 111(3). 620–627. 2 indexed citations
2.
Ghebre, Michael A., Dhananjay Desai, Beverley Hargadon, et al.. (2019). Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum. BMC Pulmonary Medicine. 19(1). 144–144. 34 indexed citations
3.
Montero, Rosa, Athula Herath, Ehsanollah Esfandiari, et al.. (2018). Defining Phenotypes in Diabetic Nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort. Scientific Reports. 8(1). 53–53. 9 indexed citations
4.
Thijs, Judith L., Ian Strickland, Carla A.F.M. Bruijnzeel-Koomen, et al.. (2017). Moving toward endotypes in atopic dermatitis: Identification of patient clusters based on serum biomarker analysis. Journal of Allergy and Clinical Immunology. 140(3). 730–737. 119 indexed citations
5.
Ghebre, Michael A., Dhananjay Desai, Amisha Singapuri, et al.. (2017). Sputum Inflammatory Mediators Are Increased inAspergillus fumigatusCulture-Positive Asthmatics. Allergy Asthma and Immunology Research. 9(2). 177–177. 9 indexed citations
6.
Gordon, Nathaniel C., Ian Strickland, Richard May, et al.. (2015). Combinatorial Screening Identifies Novel Promiscuous Matrix Metalloproteinase Activities that Lead to Inhibition of the Therapeutic Target IL-13. Chemistry & Biology. 22(11). 1442–1452. 12 indexed citations
7.
Murray, Lynne A., Huilan Zhang, Sameer R. Oak, et al.. (2014). Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model. American Journal of Respiratory Cell and Molecular Biology. 50(5). 985–994. 92 indexed citations
8.
Oak, Sameer R., Lynne A. Murray, Athula Herath, et al.. (2011). A Micro RNA Processing Defect in Rapidly Progressing Idiopathic Pulmonary Fibrosis. PLoS ONE. 6(6). e21253–e21253. 107 indexed citations
9.
Jenkins, Martin, Aiden Flynn, Trevor Smart, et al.. (2011). A statistician's perspective on biomarkers in drug development. Pharmaceutical Statistics. 10(6). 494–507. 31 indexed citations
10.
Desai, Dhananjay, Richard May, Pranabashis Haldar, et al.. (2011). Cytokine Profiling In Severe Asthma Subphenotypes Using Factor And Cluster Analysis. A3719–A3719. 1 indexed citations
11.
Johnston, Neil, Andrew McIvor, Justina M. Greene, et al.. (2010). The Christmas Season as a Risk Factor for Chronic Obstructive Pulmonary Disease Exacerbations. Canadian Respiratory Journal. 17(6). 275–281. 10 indexed citations
12.
Jackson, David H., Athula Herath, Jonathan Swinton, et al.. (2009). Considerations for powering a clinical proteomics study: Normal variability in the human plasma proteome. PROTEOMICS - CLINICAL APPLICATIONS. 3(3). 394–407. 14 indexed citations
13.
Hodgson, Darren, et al.. (2008). Biomarkers in oncology drug development. Molecular Oncology. 3(1). 24–32. 23 indexed citations
14.
Amacher, David E., Rick R. Adler, Athula Herath, & R. Reid Townsend. (2005). Use of Proteomic Methods to Identify Serum Biomarkers Associated with Rat Liver Toxicity or Hypertrophy. Clinical Chemistry. 51(10). 1796–1803. 70 indexed citations
15.
Soares, Holly, Stephen A. Williams, Peter J. Snyder, et al.. (2004). Proteomic Approaches in Drug Discovery and Development. International review of neurobiology. 61. 97–126. 9 indexed citations
16.
Morris, Joanna S., Claire Davies, Matthew R. Griffiths, et al.. (2004). Proteomic analysis of mouse mammary terminal end buds identifies axonal growth cone proteins. PROTEOMICS. 4(6). 1802–1810. 8 indexed citations
17.
Adam, Paul J., Joanne Berry, Julie Loader, et al.. (2003). Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro.. PubMed. 1(11). 826–35. 89 indexed citations
18.
Harris, Robert A., Alice Yang, Robert C. Stein, et al.. (2002). Cluster analysis of an extensive human breast cancer cell line protein expression map database. PROTEOMICS. 2(2). 212–223. 36 indexed citations
19.
Pagé, Martin, Bob Amess, R. Reid Townsend, et al.. (1999). Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proceedings of the National Academy of Sciences. 96(22). 12589–12594. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michihiko Waki Breakdown of academic impact, for papers by Laura Spruill Breakdown of academic impact, for papers by Christian Woenckhaus Breakdown of academic impact, for papers by A Desplaces Breakdown of academic impact, for papers by Siu W. Lam Breakdown of academic impact, for papers by Jane Hamlett Breakdown of academic impact, for papers by Olivier Guipaud Breakdown of academic impact, for papers by Yahya Elshimali Breakdown of academic impact, for papers by Pyong‐Gon Moon Breakdown of academic impact, for papers by Isett Laux
Rankless by CCL
2026